Relief Reports that its U.S. Collaboration Partner has Announced Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMITM (RLF-100TM/aviptadil)
GENEVA, SWITZERLAND / ACCESSWIRE / September 28, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) (“Relief“),…
IronSight AI and Fast Iron Partner to Bring AI-Powered Inventory Capture to Caterpillar, Komatsu and Volvo Equipment Dealers
WCDPQ Plans South American Expansion in 2027, Including 30 New Positions